A non opioid non addictive drug for neuropathic chronic pain, could dominate a 25 billion a year market because the drugs prescribed currently do not work , and mitigate the opioid crisis.
Ready to Ask For Funding for your company?
Post a Funding RequestAkelos inc is no longer seeking funding.